DE69628847D1 - Testverfahren und testsatz zur diagnose von autoimmunerkrankungen - Google Patents

Testverfahren und testsatz zur diagnose von autoimmunerkrankungen

Info

Publication number
DE69628847D1
DE69628847D1 DE69628847T DE69628847T DE69628847D1 DE 69628847 D1 DE69628847 D1 DE 69628847D1 DE 69628847 T DE69628847 T DE 69628847T DE 69628847 T DE69628847 T DE 69628847T DE 69628847 D1 DE69628847 D1 DE 69628847D1
Authority
DE
Germany
Prior art keywords
pct
autoimmune diseases
diagnosis
test
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69628847T
Other languages
English (en)
Other versions
DE69628847T2 (de
Inventor
Sudhir Paul
Ravishankar Kalaga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska
Original Assignee
University of Nebraska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nebraska filed Critical University of Nebraska
Application granted granted Critical
Publication of DE69628847D1 publication Critical patent/DE69628847D1/de
Publication of DE69628847T2 publication Critical patent/DE69628847T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69628847T 1995-07-21 1996-07-19 Testverfahren und testsatz zur diagnose von autoimmunerkrankungen Expired - Fee Related DE69628847T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US137095P 1995-07-21 1995-07-21
US1370 1995-07-21
PCT/US1996/012026 WO1997004125A1 (en) 1995-07-21 1996-07-19 Assay methods and kits for diagnosing autoimmune disease

Publications (2)

Publication Number Publication Date
DE69628847D1 true DE69628847D1 (de) 2003-07-31
DE69628847T2 DE69628847T2 (de) 2004-05-19

Family

ID=21695702

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69628847T Expired - Fee Related DE69628847T2 (de) 1995-07-21 1996-07-19 Testverfahren und testsatz zur diagnose von autoimmunerkrankungen

Country Status (7)

Country Link
US (1) US6130049A (de)
EP (1) EP0856065B1 (de)
AT (1) ATE243758T1 (de)
CA (1) CA2224666C (de)
DE (1) DE69628847T2 (de)
ES (1) ES2202456T3 (de)
WO (1) WO1997004125A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165799A (en) * 1996-12-10 2000-12-26 Heska Corporation Detection of anti-Fc.sub.ε R autoantibodies in asthmatics
IT1320393B1 (it) * 2000-06-05 2003-11-26 Cselt Centro Studi Lab Telecom Procedimento per il modellamento elettromagnetico di componenti esistemi elettronici.
WO2003071252A2 (en) 2002-02-15 2003-08-28 Exact Sciences Corporation Methods for analysis of molecular events
US20060030027A1 (en) * 2004-08-04 2006-02-09 Aspira Biosystems, Inc. Capture and removal of biomolecules from body fluids using partial molecular imprints
US20060045883A1 (en) * 2004-08-26 2006-03-02 Jeffrey Molldrem Anti-cancer vaccines
US20060045884A1 (en) * 2004-08-26 2006-03-02 Board Of Regents Vaccines for autoimmune and infectious disease
US7981607B2 (en) 2004-08-27 2011-07-19 Esoterix Genetic Laboratories LLC Method for detecting recombinant event
WO2006047787A2 (en) 2004-10-27 2006-05-04 Exact Sciences Corporation Method for monitoring disease progression or recurrence
US20060141547A1 (en) * 2004-11-16 2006-06-29 Das Hasi R Novel diagnostic marker, a diagnostic kit and a method for diagnosis of rheumatoid arthritis
US9777314B2 (en) 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples
US20120220875A1 (en) * 2010-04-20 2012-08-30 Suri Jasjit S Mobile Architecture Using Cloud for Hashimoto's Thyroiditis Disease Classification
US20130030281A1 (en) * 2010-04-20 2013-01-31 Jasjit S Suri Hashimotos Thyroiditis Detection and Monitoring

Also Published As

Publication number Publication date
WO1997004125A1 (en) 1997-02-06
EP0856065A4 (de) 2000-05-31
US6130049A (en) 2000-10-10
ATE243758T1 (de) 2003-07-15
DE69628847T2 (de) 2004-05-19
CA2224666C (en) 2008-11-18
EP0856065B1 (de) 2003-06-25
EP0856065A1 (de) 1998-08-05
ES2202456T3 (es) 2004-04-01
CA2224666A1 (en) 1997-02-06

Similar Documents

Publication Publication Date Title
DE69936523D1 (de) Assaysystem zur erstbehandlung von darmerkrankungen
Johnson et al. Differentiation of self and psychological reactance
DE69628847D1 (de) Testverfahren und testsatz zur diagnose von autoimmunerkrankungen
ATE366920T1 (de) Ein-schritt hybridimmunochromatographisches gerät und verfahren zur verwendung
CY1107621T1 (el) Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
AU3538195A (en) Assays and devices for the detection of extrahepatic biliary atresia
BR9710836A (pt) Ensaio de analitos usando marcas em partìculas
DE69719057D1 (de) Verfahren zur signalverstärkung
ATE234466T1 (de) Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten
ES2148577T3 (es) Eliminacion de interferencias causadas por factores reumatoides por medio de anticuerpos anti-fd.
ATE198512T1 (de) Transfizierte zelllinien die autoantigene exprimieren und ihre verwendung in immunotests zur erkennung von autoimmunkrankheiten
ATE207617T1 (de) Verfahren zur untersuchung von hausstaub
PT882229E (pt) Sistema de ensaio elisa
DE69921987D1 (de) IMMUNTEST FÜR HUMAN CHROMOGRANINE A (CgA), ANTIKÖRPER, REAGENZ UND DAZU GEEIGNETER TESTSATZ
EP0563244A4 (en) Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
DE59808639D1 (de) Verfahren zur bestimmung von schilddrüsen-autoantikörpern
MX9704717A (es) Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer.
DE68923616D1 (de) Reduzierbare indikatoren, die pyrogallol enthalten und deren verwendung.
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
ATE211825T1 (de) Verfahren zur feststellung einer allergie
DE69627352D1 (de) Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci-vermittelter neuropsychiatrischer krankheiten
DK0788595T3 (da) Fremgangsmåde til undersögelse af immumkompetance
ATE152776T1 (de) Test zur bestimmung des glaukoms (poag) durch testen peripherer blutzellen auf 3-alpha- hydroxysteroiddehydrogenase aktivität und dazu geeignetes kit

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee